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Urethral dilatation and optical internal urethrotomy are widely 
used in the treatment of male urethral strictures. In the UK, the 
treatment for urethral strictures in a general urological setting 
in the period 1991 - 1999 was urethrotomy in 72% of cases, 
dilatation in 26% and urethroplasty in only 2.4%. In patients with 
stricture recurrence, the repeat procedures were dilatation in 56% 
of cases, urethrotomy in 41% and urethroplasty in 3.6%.1 Data 
from the National Health Service in the UK during 2006 showed 
that the procedures used to treat strictures were urethrotomy or 
dilatation in 93% of cases and urethroplasty in only 7%.2   
A survey among urologists in the USA in 2002 showed that 
93% used dilatation and 86% optical urethrotomy, whereas 58% 
performed urethroplasty for the treatment of urethral strictures. 
Overall, 35% performed 1 - 5 urethroplasties a year and only 
0.7% performed more than 11 a year.3,4 An analysis of Medicare 
patients in the USA treated for urethral strictures in the period 
1992 - 2001 showed that urethrotomy comprised 51 - 58% of 
procedures performed, dilatation 35 - 44% and urethroplasty 
only 0.5 - 0.8%.5 The authors pointed out that if the estimated 
success rate is 95% for urethroplasty and 50% for urethrotomy, 
the ratio of urethrotomies to urethroplasties performed should 
be approximately 2:1, and if the success rate of urethrotomy is 
assumed to be 20%, the ratio should 5:4, much lower than the 
rates of 10:1 and even 50:1 reported in the literature.5   
Earlier studies suggested that repeated urethrotomy for 
recurrent urethral strictures may serve to ‘stabilise’ the stricture, 
thereby increasing the cumulative success rate.6,7 However, 
since the early 1980s some authors have reported that a 
second urethrotomy had a lower success rate and that repeated 
urethrotomy did not improve the cumulative success rate.8,9 
A prospective randomised study performed at our hospital 
during the period January 1991 - January 1994 compared filiform 
dilatation (n=106 patients) with optical urethrotomy (n=104) 
as treatment for male urethral strictures.10 The study compared 
the stricture recurrence rate among those who had only 1 
treatment at study entry, those who had a repeated procedure 
for stricture recurrence at 3 months, and those who underwent 
a third treatment for recurrences at 3 and 6 months after initial 
treatment. In patients not treated before randomisation the 
estimated stricture-free rate after 1, 2 or 3 repeated treatments 
was approximately 60%, 40% and 0% at 24 months, and about 
50%, 40% and 0% at 48 months. After a single dilatation or 
urethrotomy not followed by re-stricturing at 3 months, the 
estimated stricture-free rate was 55 - 60% at 24 months and 50 - 
60% at 48 months.10 
A study of patients in the UK treated during the period 1991 - 
1999 suggested that a strategy of initial urethrotomy or dilatation 
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Objective. To investigate the possible reasons for repeated 
urethral dilatation or optical internal urethrotomy rather than 
urethroplasty in the treatment of male urethral strictures.
Patients and methods. Men referred to the stricture clinic of 
our institution during the period April 2007 - March 2008 were 
reviewed and the operative urological procedures performed in 
the same period were analysed. Statistical analysis was performed 
using Student’s t-test and Fisher’s exact test (p<0.05 statistically 
significant).
Results. The mean age of the 125 men was 49.9 years (range 
12.8 - 93.4 years). Previous stricture treatment had been given 
1 - 2, 3 - 4 and 5 - 6 times in 52%, 32% and 12% of patients, 
respectively (4% had not undergone treatment). In these 
groups, previous treatment was dilatation in 70%, 76% and 
72%, urethrotomy in 26%, 15% and 28%, and urethroplasty 
in 4%, 9% and 0, respectively. The group with 5 - 6 compared 
with 1 - 2 previous treatments was significantly older (mean age 
60.2 v. 46.6 years) and had a significantly greater proportion 
with underlying co-morbidities (80% v. 52%). The group that 
had undergone urethroplasty compared with 5 - 6 repeated 
dilatations or urethrotomies was significantly younger (mean age 
48.2 v. 60.2 years) with a lower prevalence of co-morbidities (47% 
v. 80%). During the study period urethroplasty was performed in 
16 (2%) of 821 inpatients, whereas 55 men were seen who had 
undergone ≥3 previous procedures, indicating that urethroplasty 
was performed in less than one-third of cases in which it would 
have been the optimal treatment. Owing to limited theatre time, 
procedures indicated for malignancy, urolithiasis, renal failure 
and congenital anomalies were performed more often than 
urethroplasty. 
Conclusions. Factors that possibly influenced the decision 
to perform repeated urethrotomy or dilatation instead of 
urethroplasty were limited theatre time, increased patient age 
and the presence of underlying co-morbidities. 
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followed by urethroplasty for recurrent stricture is the most 
cost-effective strategy.1 In contrast, a study from the USA using 
a cost minimisation decision analysis model for the treatment 
of a 2 cm bulbar stricture suggested that urethrotomy was more 
costly than immediate urethroplasty, unless the estimated long-
term success of urethrotomy was greater than 40%.11 A study 
from the USA considered the costs of treatment as well as lost 
wages from convalescence and suggested that in the case of a 1 
- 2 cm bulbar urethral stricture the strategy of one urethrotomy 
before proceeding to urethroplasty was the least costly, unless the 
expected success rate of urethrotomy was less than 35%.12 
It has been suggested that the reasons for utilisation 
of repeated urethrotomy are lack of urethroplasty expertise 
among urologists and perverse financial incentives preventing 
the referral of patients to centres with expertise.13 In the USA, 
physician reimbursement for urethroplasty is approximately 
twice the amount for urethrotomy, suggesting that there is a 
financial disincentive to performing urethroplasty.3 
Despite evidence on the limited usefulness of repeated 
dilatation and urethrotomy provided by the randomised 
controlled trial in our hospital, it remains unknown whether this 
evidence has been applied in practice. The aim of this study was 
to determine the prevalence of, and possible reasons for, the use 
of repeated dilatation or urethrotomy rather than urethroplasty 
in our hospital. 
Patients and methods 
Male patients attending the stricture clinic of the general urological 
service at out institution (a tertiary-level public sector academic 
teaching hospital serving a largely indigent population without 
private medical insurance) were interviewed using a structured 
questionnaire on demographic, socio-economic and clinical 
aspects of the subject’s medical history. Additional information 
about stricture aetiology and management was obtained from the 
patient’s medical records. 
Patients referred to the stricture clinic included all untreated 
men with a newly diagnosed or suspected urethral stricture, and 
all men followed up after previous stricture treatment. All patients 
had been treated at our hospital, and were not referred because 
of failed stricture treatment elsewhere. Apart from a full history 
and clinical examination, evaluation included the international 
prostate symptom score (IPSS), uroflowmetry and ultrasound 
measurement of the post-void residual. The urethra was evaluated 
by calibration using Jacques or Nelaton catheters in all patients. 
Retrograde and/or prograde urethrography and flexible or rigid 
urethrocystoscopy was performed in patients when the F18 
catheter could not be passed. Stricture was defined as a urethral 
lumen less than F18 in diameter. 
Treatment decisions were made in consultation with patients on 
an individual basis and not according to a rigid protocol. Most of 
the patients evaluated during the study period had been treated 
Table 1. Comparison of clinical findings according to stricture aetiology 
Stricture aetiology 
Urethritis Trauma (external) Trauma (internal) Unknown
No. 32 19 48 26
% 26 15 38 21
Age (yrs)
   Mean 46.1 36.3* 55.5* 53.8*
   Range 23 - 83 13 - 61 13 - 84 31 - 93
Stricture location (%)
   Bulbar 84 68 74 73 
   Penile 34 26 30 46 
   Membranous 25 32 20 15 
   Meatal 6 5 15 12 
Stricture length 
   Mean (cm) 1.5 2.3 1.8 1.1
   Range (cm) 0.5 - 3 0.5 - 5 0.5 - 5 0.5 - 3
   <2.1 cm (%) 57.1 66.7 55 53.3
Previous stricture treatment (%)
   0 - 2 69 50 42 56 
   3 - 6 31 50 58 44 
Follow-up (mo.)
   Mean  39.2 23.4* 39.7 39.9
   Range 3.3 - 444 0 - 139.6 0.5 - 328 3.8 - 300.4
Stricture-free at last follow-up (%) 75* 53 45* 54
* = statistically significant.   
84          SAJS VOL 50, NO. 3, AUGUST 2012   
SAJS
previously by several different urology specialists and residents in 
our hospital over the course of several years, with no consistent 
documentation of the reason(s) for specific treatment decisions. 
Follow-up after treatment was usually scheduled at 3, 6 and 12 
months and annually thereafter if no stricture recurrence was 
found. After every retreatment, follow-up was rescheduled at 3, 6 
and 12 months and annually thereafter.  
The operative procedures performed on inpatients in the 
main urology theatres during the period of this survey were also 
analysed to determine the number of urethroplasties performed. 
The study protocol for the perusal of medical records was 
approved by the local institutional review board, and written 
informed consent for completion of the structured questionnaire 
was obtained from all study subjects. 
All data were entered on an Excel spreadsheet. Statistical 
analysis was performed using GraphPad Instat software. Student’s 
t-test was used for comparison of means and Fisher’s exact test 
for contingency table analysis. A two-tailed p-value <0.05 was 
accepted as statistically significant.
Results
A total of 125 men with proven urethral strictures were evaluated 
during the period April 2007 - March 2008. The mean patient 
age was 49.9 years (median 47.7, range 12.8 - 93.4 years). Overall, 
the mean period between first diagnosis of urethral stricture and 
last follow-up was 36.9 months (median 14.4, range 0.5 - 444 
months). 
The causes of the strictures were classified as previous urethritis 
(infective/inflammatory), external trauma (perineal or straddle 
injury, pelvic fracture or gunshot wound), internal (iatrogenic) 
trauma (catheterisation or transurethral resection) and idiopathic 
(Table 1). Overall, stricture location was bulbar in 76%, penile in 
34%, membranous in 22% and meatal in 10% (some strictures 
involved more than one part of the urethra). The stricture was 
Table 2. Comparison of clinical findings according to number of previous stricture treatments  
                    No. of previous stricture treatments
1 - 2 3 - 4 5 - 6 
No. 65 40 15
% of total group 52 32 12
Procedure (%)
   Urethral dilatation 70 76 72 
   Internal urethrotomy 26 15 28 
   Urethroplasty 4 9 0
Age (yrs) 
   Mean 46.6 49.7 60.2* 
   Range 21.6 - 76 12.8 - 82.7 34.2 - 84.2
Stricture aetiology (%)
   Urethritis 34 18 20 
   Trauma (external) 17 23 0
   Trauma (internal) 29 40 67 
   Idiopathic 20 20 13 
Co-morbidities, total (%) 52 73 80*
Stricture location (%)
   Bulbar 79 78 80 
   Penile 34 28 53 
   Membranous 25 20 13 
   Meatal 3 18 27 
Stricture length 
   Mean (cm) 1.3 1.7 2.2
   Range (cm) 0.5 - 5 0.5 - 3 0.5 - 5
   <2.1 cm (%) 55 59 57 
Follow-up (mo.)
   Mean 15.6 54.8* 85.4* 
   Range 0.5 - 83.2 3.3 - 444.4 11.9 - 300.4
Stricture-free at last follow-up (%) 65 48 50 
* = statistically significant.  
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single in 76% of cases, and the mean stricture length was 1.6 cm 
(median 1.0, range 0.5 - 5 cm), the length being 2 cm or less in 
56% of cases. A comparison of the clinical findings according to 
stricture aetiology is shown in Table 1.  
Overall co-morbidities in the study cohort included 
hypertension (25%), previous or current tuberculosis (18%), renal 
failure (11%), ischaemic heart disease (9%), obstructive airway 
disease (8%), erectile dysfunction (8%), cancer (7%), diabetes 
mellitus (6%), epilepsy (4%), arthritis (4%), brain damage 
(3%) and depression (2%) (some patients had more than one 
co-morbidity). 
At the time of evaluation, 4% of patients had not undergone 
treatment, and 52% had undergone 1 - 2 and 44% 3 - 6 previous 
stricture treatments. The stricture aetiology, co-morbidities and 
clinical findings were compared according to the number of 
previous stricture treatments (Table 2). The patient groups with 
previous urethroplasty and those with 5 - 6 previous dilatations 
or urethrotomies were compared with each other (Table 3). 
Among the patients who had undergone urethroplasty, subsequent 
dilatation or urethrotomy was performed 1 - 2 times in 53%, 3 - 4 
times in 27% and not at all in 20%.   
During the period April 2007 - March 2008 a total of 831 
inpatients underwent a total of 1 313 urological procedures in the 
main operating theatre of our hospital (Table 4). 
 Discussion 
The current study presents a cross-section of men with a diagnosis 
of urethral stricture evaluated during the course of a year in the 
general urological service of a tertiary-level academic hospital. The 
study cohort probably comprised a selected population, because 
men who were symptom-free after previous stricture treatment 
were probably less likely to comply with scheduled follow-up, 
whereas patients with symptoms due to stricture recurrence were 
more likely to attend. The results of prior treatment were therefore 
probably biased towards failed rather than successful treatment.  
During the study period there were 55 men who had had 3 
or more previous stricture treatments. During the same period, 
urethroplasty was performed on 16 patients, 2% of the total 
number who underwent inpatient urological operations (Table 
4). This means that, on average, less than one-third of men who 
should have had a urethroplasty did in fact undergo the procedure. 
A previous study showed that during the period 1975 - 2002 
the average annual number of inpatient operative urological 
procedures performed in our hospital decreased by a third, largely 
due to a 35% reduction in bed numbers and theatre time resulting 
from budgetary restrictions.14 
Table 3. Comparison of clinical findings in men who 
underwent urethroplasty versus dilatation or urethrotomy 
5 - 6 times    
Urethroplasty
5 - 6 
dilatations or 
urethrotomies 
No. 15 15
Age (yrs)
   Mean 48.2 60.2* 
   Range 14.4 - 73.8 34.2 - 84.2
Stricture aetiology (%)
   Urethritis 13 20 
   Trauma external 33 0*
   Trauma internal 33 67*
   Idiopathic 20 13 
Sexually transmitted 
infection (%)
    Syphilis serology 
positive
7 7 
   HIV serology positive 8 7 
Co-morbidities, total (%) 47 80*
Complications (%)
   Retention 27 13*
   Other complications 33 27 
Stricture location (%)
   Bulbar 86 80 
   Penile 33 53 
   Membranous 27 13 
   Meatal 13 27 
Stricture length 
   Mean (cm) 2.8 2.2
   Range (cm) 1 - 5 0.5 - 5
   <2.1 cm (%) 80 57 
Follow-up (mo.)
   Mean  60.4 85.4*
   Range 4.9 - 300 11.9 - 300.4
Stricture-free at last 
follow-up (%)
56 50 
* = statistically significant. 
Table 4. Urological procedures performed on inpatients in 
the main theatre during the study period 
No. %
Patients 821
Procedures 1 313
1. Transurethral resection of bladder tumour 138 16.8 
2. Prostatectomy (transurethral, open, radical) 115 14.0 
3. Nephrectomy, heminephrectomy 66 8.0 
4. Orchidopexy 57 6.9 
5. Hernia repair (fluid hernia, inguinal hernia) 56 6.8 
6. Nephrolithotomy 51 6.2 
7.  Renal transplantation, Tenckhoff catheter, 
arteriovenous fistula 
45 5.5 
8. Circumcision 36 4.4 
9. Hypospadias repair 30 3.7
10. Bricker diversion, cystectomy 23 2.8 
11. Orchidectomy (bilateral or radical) 21 2.6 
12. Urethroplasty 16 2.0 
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Clearly, limited operating time is a major factor in selecting 
patients for surgery. Whereas urethral stricture disease affects the 
patient’s quality of life and may lead to serious complications, it 
is rarely life-threatening. The procedures performed more often 
than urethroplasty in our hospital were mainly indicated for 
malignancy, urolithiasis, renal failure and congenital anomalies 
(Table 4). Although repeated dilatation or internal urethrotomy is 
not optimal treatment, its continued use in our hospital is at least 
partly determined by selection pressures due to limited operating 
time. The reasons for the widespread use of repeated dilatation 
or urethrotomy rather than urethroplasty reported in the USA 
and the UK remain unknown, because no published studies have 
directly examined this question. However, limited operating room 
time due to budgetary constraints is unlikely to be an important 
reason. 
In this study cohort, 3 or more procedures were performed in 
a greater proportion of men with strictures caused by iatrogenic 
(58%) or external trauma (50%) than urethritis (31%). Mean 
follow-up was significantly shorter in the group with strictures 
caused by external trauma, possibly because younger men are less 
likely to return for routine follow-up if asymptomatic. Another 
possible explanation of the shorter follow-up is that traumatic 
strictures that recur after treatment do so within a shorter period 
of time than strictures with other causes (Table 1).  
In this study 44% of the men had undergone 3 - 6 previous 
stricture treatments. Dilatation was the most common form of 
treatment (70 - 76%), urethrotomy was used less often (15 - 28%) 
and urethroplasty was used least often (4 - 9%), and never as a 
5th or 6th procedure (Table 2). Compared with those who had 
undergone 1 - 2 procedures, the group of men who had undergone 
5 - 6 procedures were significantly older (60.2 v. 46.6 years), had 
a greater proportion with iatrogenic strictures (67% v. 29%), 
underlying co-morbidities (80% v. 52%) and involvement of the 
penile urethra (53% v. 34%) and meatus (27% v. 3%) rather than 
the membranous urethra (13% v. 25%), and had a greater mean 
stricture length (2.2 v. 1.3 cm) and significantly longer follow-up, 
but no significant difference was noted with regard to stricture-
free rate at last follow-up (50% v. 65%) (Table 2). 
A recent paper by Santucci and Eisenberg reported that in 
136 patients who underwent urethrotomy during the period 
1994 - 2009 at a centre in the USA the stricture-free rates after 
1, 2, 3, 4 and 5 urethrotomies were 8%, 6%, 9%, 0% and 0%, 
respectively, much lower success rates than previously reported. 13 
However, the analysis was based on only 76 (56%) of the patients 
who underwent urethrotomy, because the authors excluded 36 
patients with complex strictures and 24 who were lost to follow-
up. It is probable that patients lost to follow-up were stricture-free, 
whereas those with recurrence returned for further treatment. 
Moreover, the study cohort was probably a highly selected group 
with stricture recurrence after repeated urethrotomy, referred to a 
centre with expertise in urethroplasty.13
Interestingly, the mean age of the patients in the above study 
increased with the number of urethrotomies, being 53, 57, 61, 68 
and 74 years in those who had undergone 1, 2, 3, 4 and 5 previous 
urethrotomies, respectively.13 This indicates that the decision to 
perform repeated urethrotomy was probably influenced by the 
patient’s age and possibly by other undefined factors. The low 
success rates of first and second urethrotomy in this study (8% and 
6%) are at variance with a large body of evidence in the literature, 
where the success rates range from 20% to 80%.15  
In the current study the use of repeated procedures was 
associated with significantly increasing patient age and an 
increasing prevalence of co-morbidities. The significantly longer 
follow-up in the groups with repeated treatment indicates a greater 
tendency to stricture recurrence with longer follow-up (Table 3). 
Presumably many (if not most) patients who remained recurrence-
free after initial treatment would not have returned for follow-up. 
This is the most probable explanation for the similar stricture-
free rates at last follow-up, regardless of the number of previous 
treatments (Table 3).    
Factors associated with urethroplasty rather than repeated 
dilatation or urethrotomy (5 - 6 times) included younger age 
(48.2 v. 60.2 years), external trauma rather than iatrogenic trauma 
as aetiology (33% v. 0% and 33% v. 67%, respectively), lower 
prevalence of co-morbidities (47% v. 80%), and membranous 
rather than penile location of the stricture (27% v. 13% and 
33% v. 53%, respectively) (Table 3). The fact that dilatation or 
urethrotomy was performed 1 - 4 times after urethroplasty in 
80% of these patients indicates selection bias towards men with 
stricture recurrence after urethroplasty, who were more likely to 
return for follow-up than those remaining stricture-free. This 
probably also explains the similar stricture-free rate at last follow-
up after urethroplasty compared with 5 - 6 repeated endoscopic 
procedures (56% v. 50%).  
This study has some limitations. Although patients were 
prospectively evaluated during the course of a year, the assessment 
of previous stricture treatment was retrospective and based on 
clinical records. Since it was not a prospective follow-up study of 
all patients who underwent each of the treatment modalities, and 
because asymptomatic patients were probably less likely to return 
for long-term routine follow-up, the stricture-free rates found 
at follow-up do not reflect treatment efficacy, and are probably 
biased towards treatment failure rather than success. However, the 
factors determining selection bias were probably the same for all 
patients, regardless of previous treatment, which confers validity 
to the comparison of the treatment groups. Unfortunately, the 
reason(s) for performing repeated dilatation or urethrotomy rather 
than urethroplasty were not specifically recorded by the treating 
surgeons, so the reasons for treatment choices can only be inferred 
from analysis of the data.    
Conclusions 
Factors that probably influenced the decision to perform repeated 
urethrotomy or dilatation instead of urethroplasty in this study 
were limited theatre time, increased patient age and the presence 
of underlying co-morbidities, rather than the aetiology or 
characteristics of the strictures alone. 
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